JP2014240383A5 - - Google Patents

Download PDF

Info

Publication number
JP2014240383A5
JP2014240383A5 JP2014102285A JP2014102285A JP2014240383A5 JP 2014240383 A5 JP2014240383 A5 JP 2014240383A5 JP 2014102285 A JP2014102285 A JP 2014102285A JP 2014102285 A JP2014102285 A JP 2014102285A JP 2014240383 A5 JP2014240383 A5 JP 2014240383A5
Authority
JP
Japan
Prior art keywords
mirtazapine
cancer
subject
acceptable salt
pharmacologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014102285A
Other languages
English (en)
Japanese (ja)
Other versions
JP6452954B2 (ja
JP2014240383A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014102285A priority Critical patent/JP6452954B2/ja
Priority claimed from JP2014102285A external-priority patent/JP6452954B2/ja
Publication of JP2014240383A publication Critical patent/JP2014240383A/ja
Publication of JP2014240383A5 publication Critical patent/JP2014240383A5/ja
Application granted granted Critical
Publication of JP6452954B2 publication Critical patent/JP6452954B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014102285A 2013-05-16 2014-05-16 癌転移抑制剤 Expired - Fee Related JP6452954B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014102285A JP6452954B2 (ja) 2013-05-16 2014-05-16 癌転移抑制剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013104409 2013-05-16
JP2013104409 2013-05-16
JP2014102285A JP6452954B2 (ja) 2013-05-16 2014-05-16 癌転移抑制剤

Publications (3)

Publication Number Publication Date
JP2014240383A JP2014240383A (ja) 2014-12-25
JP2014240383A5 true JP2014240383A5 (https=) 2017-07-06
JP6452954B2 JP6452954B2 (ja) 2019-01-16

Family

ID=52139848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014102285A Expired - Fee Related JP6452954B2 (ja) 2013-05-16 2014-05-16 癌転移抑制剤

Country Status (1)

Country Link
JP (1) JP6452954B2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6915865B2 (ja) * 2017-10-03 2021-08-04 学校法人 愛知医科大学 Ｎｏ産生抑制剤及び固形腫瘍に対する転移・浸潤抑制剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain

Similar Documents

Publication Publication Date Title
WO2016004305A3 (en) Inhibitors of bruton's tyrosine kinase
CY1125326T1 (el) Προαιρετικως συντηγμενα ετεροκυκλυλο- υποκατεστημενα παραγωγα πυριμιδινης χρησιμα για τη θεραπευτικη αγωγη φλεγμονωδων, μεταβολικων, ογκολογικων και αυτοανοσων ασθενειων.
CY1120941T1 (el) Παραγωγα φαινυλοτριαζολιου υποκατεστημενα με υδροξυαλκυλιο και χρησεις αυτων
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
PH12018500284A1 (en) 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
WO2016196776A3 (en) Inhibitors of bruton's tyrosine kinase
ZA201800022B (en) Substituted heterocyclyl derivatives as cdk inhibitors
MX375752B (es) Inhibidores de tirosina quinasa de bruton.
JP2016533366A5 (https=)
WO2015048689A8 (en) Inhibitors of bruton's tyrosine kinase
WO2015148415A3 (en) Use of the fl118 core chemical structure platform to generate fl118 derivatives for treatment of human disease
MY187047A (en) Selective pyy compounds and uses thereof
WO2015106128A3 (en) Rnai agents modified at the 4'-c-position
NZ728392A (en) High dosage strength tablets of rucaparib
MA34019B1 (fr) Aryltriazolone liée à un bis-aryle et son utilisation
PH12016500420A1 (en) Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
EA201691674A1 (ru) 1,2-замещенные циклопентаны в качестве антагонистов рецептора орексина
JOP20190263A1 (ar) عوامل RNAi لتثبيط التعبير عن Alpha- EnaC وطرق استخدامها
PH12016502353A1 (en) Pharmaceutical composition
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
JP2015502926A5 (https=)
TW201613577A (en) Pharmaceutical combinations
CL2014001959A1 (es) Compuestos derivados de fenil-1h-imidazo[1,2-b]pirazol sustituidos; procedimiento de preparacion; composicion farmaceutica; y el uso en el tratamiento del cancer.
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
UA116499C2 (uk) (r)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині